Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian cost-effectiveness analysis from clinical trial data.

A O'Hagan1, J W Stevens, J Montmartin

  • 1Department of Probability and Statistics, University of Sheffield, Sheffield S3 7RH, UK. a.ohagan@sheffield.ac.uk

Statistics in Medicine
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk: A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

PharmacoEconomics·2016
Same author

Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.

The British journal of surgery·2014
Same author

Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).

The British journal of surgery·2013
Same author

Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2013
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

The incremental cost-effectiveness acceptability curve (CEAC) helps assess treatment value. Bayesian methods using clinical trial data and prior information improve cost-effectiveness analysis conclusions.

Area of Science:

  • Health economics
  • Biostatistics
  • Clinical trial analysis

Background:

  • Cost-effectiveness analysis (CEA) is crucial for healthcare decision-making.
  • The incremental cost-effectiveness acceptability curve (CEAC) is a key tool for CEA.
  • Bayesian methods offer a robust framework for analyzing uncertainty in CEA.

Purpose of the Study:

  • To present Bayesian computations for the incremental CEAC.
  • To analyze the impact of prior information on CEAC.
  • To demonstrate improved cost-effectiveness assessment using Bayesian approaches.

Main Methods:

  • Utilized Bayesian computational methods for CEAC.
  • Incorporated data on both costs and efficacy from clinical trials.
  • Explored various formulations of prior information.

Related Experiment Videos

Main Results:

  • Demonstrated Bayesian calculations for the incremental CEAC.
  • Showed that prior information significantly strengthens posterior inference.
  • Achieved more conclusive cost-effectiveness assessments.

Conclusions:

  • Bayesian computations provide a powerful tool for generating the incremental CEAC.
  • Incorporating prior information enhances the reliability of cost-effectiveness conclusions.
  • These analyses are feasible with readily available Bayesian software.